Please login to the form below
biopharma
This page shows the latest biopharma news and features for those working in and with pharma, biotech and healthcare.
Teva wins FDA OK for crucial migraine drug
ahead of late-stage rivals from Eli Lilly (galcanezumab) and Alder Biopharma (eptinezumab).
Latest news
-
Gilead targets hep B in half a billion dollar deal with Precision BioSciences
Biopharma looks to genome editing platform to discover hepatitis B cure.
-
Home-grown colorectal cancer drug approved in China
The approval has sparked a $13.6m milestone payment from Lilly to Chi-Med, and is a major achievement for the Chinese biopharma company, particularly as other companies have struggled to
-
Confidence in UK’s post-Brexit healthcare sector on the wane
The report notes that in the biopharma sector, the proportion of non-UK employees working in companies in the UK ranges from 17% to 41%, and tends to be higher in
-
Vernalis accepts £33m takeover offer from Ligand Pharma
and aminopeptidase inhibitor tosedostat for leukaemia, which is partnered with CTI Biopharma.
-
Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity
in diabetes sales offset by fall in biopharma products such as haemophilia therapies and growth factors.
More from news
Approximately 10 fully matching, plus 425 partially matching documents found.
Latest Intelligence
-
Cancer immunotherapy: What's on the horizon?
It’s a whole new therapeutic vista of course, so setbacks are only to be expected, and there are plenty of other new targets in the biopharma industry’s sights.
-
Diversity and inclusion in the pharma industry
biopharma industry is one of the most powerful and important industries today, directly affecting the lives of billions of people around the world on a daily basis.
-
How can pharma build bridges with HCPs online?
What is holding pharma back? As referenced in the report, the highly regulated environment in which pharma and biopharma companies operate is partly to blame for their failure to harness the
-
Accelerating diagnosis in rare disease
Timely diagnosis in rare disease is one of the fundamental unmet needs for patients, healthcare professionals (HCPs) and biopharma.
-
Accelerating diagnosis in rare disease
Accelerating diagnosis in rare disease. Timely diagnosis in rare disease is one of the fundamental unmet needs for patients, healthcare professionals (HCPs) and biopharma.
More from intelligence
Approximately 0 fully matching, plus 64 partially matching documents found.
Latest appointments
-
BMS appoints CCO, Stephen Davies joins Eisai and more
Officially joining the biopharma on 1 October, Schuermans will play a part in bringing together Sobi’s manufacturing operations/biological development and supply, quality, supply chain, procurement and environment and safety
-
Marinomed appoints CFO, Robin Brown is named chair of Medicines Discovery Catapult, Filippo Petti joins Ceylad and Vivienne Fox to chair RFI
Ceylad appoints new CFO. Clinical-stage biopharma focused on the development of CAR-T cell therapies has announced that Filippo Petti has been appointed as Chief Financial Officer.
-
Weekly industry appointments
Here you will find a recent selection of movers within pharma, biopharma, biotech and CMOs.
-
Axovant poaches Allergan’s and Teva’s chief medical and science officers
Gavin Corcoran and Michael Hayden join the biopharma. Clinical stage biopharmaceutical group Axovant has appointed Gavin Corcoran as its new executive vice president of research and development.
-
Abeona Therapeutics appoints new additions to board of directors
Abeona Therapeutics appoints new additions to board of directors. Stefano Buono and Richard Van Duyne join the biopharma.
More from appointments
Approximately 8 fully matching, plus 135 partially matching documents found.
Latest from PMHub
-
Training the next generation of biotech leaders
biopharma. He is also coordinating outreach activities with school children to inspire future generations of biochemical engineers.
-
Immunotherapies in oncology: the future of cancer treatment lies in combinations and partnerships
Immunotherapies in oncology: the future of cancer treatment lies in combinations and partnerships. Anne Legendre reviews the scientific rationale behind immunotherapy combinations and Frances Hendry examines how partnerships, co-marketing and
-
Preparing for biopharma marketing in 2020 and beyond - Who is the marketer of the future?
Preparing for biopharma marketing in 2020 and beyond - Who is the marketer of the future? ... Who is the Marketer of the Future? Preparing for Biopharma Marketing in 2020 and Beyond.
-
Delivering on what matters to patients
there when I need you?” In other words, are biopharma companies really present in ways that truly matter to patients and in places where patients want them to be? ... If the statement “ Not everything that matters can be measured, and not everything
-
White paper download: Creating a patient-led brand strategy
To survive in an increasingly competitive marketplace, biopharma companies need to create strong, patient-centric brands that differentiate themselves from their competitors and convince the payer, physician and patient of their
More from PMHub
Approximately 1 fully matching, plus 19 partially matching documents found.
Featured jobs
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Senior Writer, Healthcare Advertising, London
-
Excellent package
-
Systematic Review Lead- London
-
Negotiable
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Medical Writers Required - Hertfordshire
-
Competitive
-
Sudler London - Account Director
-
Competitive
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Associate Scientific Director
-
Salary TBC
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
- Account Director or Senior Account Director
-
Salary TBC
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Sudler London - Senior Medical Writer
-
Competitive
Subscribe to our email news alerts
- Tox trouble stalls Sosei/Allergan Alzheimer’s drug
- London cancer hub launched by Cancer Research UK
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Making a Difference - The Future of Pharma
- AZ prepares to file COPD triple, taking on rival GSK
- Controversy grows around GP at Hand service after minister’s endorsement
PMHub
Apex.co.uk Conferences, Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
